Evidence map›Paper›PMID 28819009›Full record

ReviewThe Biochemical journal2017

The AAA+ ATPase p97, a cellular multitool.

Lasse Stach, Paul S Freemont

Open access · hybridAbstract readReview
In one paragraph

Review in The Biochemical journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 93 papers.

0numbers the graph read from it
0cells of the map it votes in
93citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

93 citing papers in PubMed, 136 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. AAA+ ATPase chaperone p97/VCPNature communications · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

33 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Lasse StachSection of Structural Biology, Department of Medicine, Imperial College London, London, U.K.
Paul S FreemontSection of Structural Biology, Department of Medicine, Imperial College London, London, U.K. p.freemont@imperial.ac.uk.
Institute of Structural and Molecular Biology · GB

Funding

Cancer Research UK 13449Cancer Research UK CRUK A13449
6 · The paper itself

Abstract

The AAA+ (ATPases associated with diverse cellular activities) ATPase p97 is essential to a wide range of cellular functions, including endoplasmic reticulum-associated degradation, membrane fusion, NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) activation and chromatin-associated processes, which are regulated by ubiquitination. p97 acts downstream from ubiquitin signaling events and utilizes the energy from ATP hydrolysis to extract its substrate proteins from cellular structures or multiprotein complexes. A multitude of p97 cofactors have evolved which are essential to p97 function. Ubiquitin-interacting domains and p97-binding domains combine to form bi-functional cofactors, whose complexes with p97 enable the enzyme to interact with a wide range of ubiquitinated substrates. A set of mutations in p97 have been shown to cause the multisystem proteinopathy inclusion body myopathy associated with Paget's disease of bone and frontotemporal dementia. In addition, p97 inhibition has been identified as a promising approach to provoke proteotoxic stress in tumors. In this review, we will describe the cellular processes governed by p97, how the cofactors interact with both p97 and its ubiquitinated substrates, p97 enzymology and the current status in developing p97 inhibitors for cancer therapy.

Indexed as

Models, BiologicalAdenosine TriphosphatasesAllosteric RegulationAnimalsAntineoplastic AgentsBinding SitesChromatin Assembly and DisassemblyCoenzymesDrugs, InvestigationalEndoplasmic Reticulum-Associated DegradationEnzyme InhibitorsHumansMembrane FusionMolecular ConformationNF-kappa B p50 SubunitNuclear ProteinsAdenosine TriphosphatasesAntineoplastic AgentsCoenzymesDrugs, InvestigationalEnzyme InhibitorsNF-kappa B p50 SubunitNFKB1 protein, humanNuclear Proteinsp97 ATPase

Identifiers

PMID28819009
PMCPMC5559722
OpenAlexW2746939261

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.